Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688016's PB Ratio is ranked worse than 60.99% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs SHSE:688016: 2.71
During the past 12 months, Shanghai Microport Endovascular Medtech Co's average Book Value Per Share Growth Rate was 9.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 27.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 26.80% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai Microport Endovascular Medtech Co was 86.40% per year. The lowest was 17.30% per year. And the median was 39.40% per year.
Back to Basics: PB Ratio
Shanghai Microport Endovascular Medtech Co (SHSE:688016) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Shanghai Microport Endovascular Medtech Co PB Ratio Related Terms
Shanghai Microport Endovascular Medtech Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Microport Endovascular Medtech Co PB Ratio Chart
Shanghai Microport Endovascular Medtech Co Annual Data
For the Medical Devices subindustry, Shanghai Microport Endovascular Medtech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Microport Endovascular Medtech Co PB Ratio vs Medical Devices & Instruments Industry
Shanghai Microport Endovascular Medtech Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shanghai Microport Endovascular Medtech Co (SHSE:688016) has a PB Ratio of 2.71 as of Jul. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Microport Endovascular Medtech Co and its competitors. This is 66% below median its historical median of 7.91. Over the past decade, Shanghai Microport Endovascular Medtech Co's PB Ratio has ranged from 2.45 to 47.60. According to the industry distribution chart, Shanghai Microport Endovascular Medtech Co ranks #480 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 61%.
Is Shanghai Microport Endovascular Medtech Co's PB Ratio too high?
Shanghai Microport Endovascular Medtech Co's current PB Ratio of 2.71 is 66% below median its 10-year median of 7.91. Over the past 10 years, this metric has ranged from a low of 2.45 to a high of 47.60. The Medical Devices & Instruments industry median PB Ratio is 2.04. Shanghai Microport Endovascular Medtech Co's value of 2.71 is 32.8% above this industry median. Based on the distribution chart, Shanghai Microport Endovascular Medtech Co ranks #480 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shanghai Microport Endovascular Medtech Co has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Microport Endovascular Medtech Co's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Microport Endovascular Medtech Co ranks #480 out of 787 companies for PB Ratio. This places Shanghai Microport Endovascular Medtech Co in the lower half of its industry. The industry median PB Ratio is 2.04. Shanghai Microport Endovascular Medtech Co's value of 2.71 is 32.8% above this benchmark. Historically, Shanghai Microport Endovascular Medtech Co's own PB Ratio has ranged from 2.45 to 47.60 over the past decade. While the company's 10-year median is 7.91 vs. the industry median of 2.04, Shanghai Microport Endovascular Medtech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Microport Endovascular Medtech Co's current PB Ratio of 2.71 is 32.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Microport Endovascular Medtech Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Microport Endovascular Medtech Co's current PB Ratio is 2.71, which is 66% below median its own 10-year median of 7.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Microport Endovascular Medtech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Microport Endovascular Medtech Co (SHSE:688016) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥121.58, compared to a current price of ¥92.89 — trading 23.6% below its estimated fair value. The current PB Ratio is 2.71, which is 66% below median its 10-year median of 7.91 and 32.8% above the Medical Devices & Instruments industry median of 2.04. Shanghai Microport Endovascular Medtech Co's overall GF Score™ is 100/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shanghai Microport Endovascular Medtech Co (SHSE:688016), the current PB Ratio is 2.71 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Microport Endovascular Medtech Co (SHSE:688016) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Microport Endovascular Medtech Co stock appears to be undervalued.
The current stock price of ¥92.89 is trading 23.6% below its estimated GF Value™ of ¥121.58.
GuruFocus considers Shanghai Microport Endovascular Medtech Co to be Modestly Undervalued.
Key valuation signals for SHSE:688016:
PB Ratio: 2.71 (66% below median its 10-year median of 7.91)
GF Value™: ¥121.58 vs. price of ¥92.89 (23.6% below fair value)
Industry Position: 32.8% above the Medical Devices & Instruments median (#480 of 787)
No single metric tells the full story. See the SHSE:688016 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Microport Endovascular Medtech Co Business Description
Shanghai Microport Endovascular Medtech Co Ltd is engaged in the Research, development, production and sales of interventional medical devices for the aorta and peripheral blood vessels.
100GF Score
Get the complete analysis for SHSE:688016
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688016 has been successfully added to your 
